<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Coffee on MacWorks</title><link>https://macworks.dev/tags/coffee/</link><description>Recent content in Coffee on MacWorks</description><generator>Hugo</generator><language>en</language><atom:link href="https://macworks.dev/tags/coffee/index.xml" rel="self" type="application/rss+xml"/><item><title>中文科技资讯</title><link>https://macworks.dev/docs/today/tech-news-cn-2026-07-26/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://macworks.dev/docs/today/tech-news-cn-2026-07-26/</guid><description>&lt;h1 id="chinese-tech-daily--2026-07-26"&gt;Chinese Tech Daily — 2026-07-26&lt;a class="anchor" href="#chinese-tech-daily--2026-07-26"&gt;#&lt;/a&gt;&lt;/h1&gt;
&lt;h2 id="top-story"&gt;Top Story&lt;a class="anchor" href="#top-story"&gt;#&lt;/a&gt;&lt;/h2&gt;
&lt;p&gt;A deeply concerning medical ethics scandal has surfaced involving a fatal gene-editing trial at Shanghai Xinhua Hospital. A 6-year-old girl died shortly after receiving an experimental treatment for a rare genetic disorder, leading the Shanghai Jiao Tong University School of Medicine to launch a formal investigation into the research team led by Qiu Zilong. The case, which was not publicly disclosed beforehand, raises major red flags around clinical risk assessment, medical ethics, and the transparency of experimental human trials in China.&lt;/p&gt;</description></item></channel></rss>